Cargando…
Left ventricular hypertrophy as a predictor of cardiovascular outcomes after transcatheter aortic valve replacement
AIMS: This study aimed to clarify the relationship between cardiovascular prognosis and left ventricular hypertrophy (LVH) in patients with severe aortic stenosis who underwent transcatheter aortic valve replacement (TAVR) and to investigate the relationship between cardiac sympathetic nerve (CSN) f...
Autores principales: | , , , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10053161/ https://www.ncbi.nlm.nih.gov/pubmed/36725669 http://dx.doi.org/10.1002/ehf2.14305 |
_version_ | 1785015346681348096 |
---|---|
author | Ito, Nobuyasu Zen, Kan Takahara, Motoyoshi Tani, Ryotaro Nakamura, Shunsuke Fujimoto, Tomotaka Takamatsu, Kazuaki Yashige, Masaki Kadoya, Yoshito Yamano, Michiyo Yamano, Tetsuhiro Nakamura, Takeshi Yaku, Hitoshi Matoba, Satoaki |
author_facet | Ito, Nobuyasu Zen, Kan Takahara, Motoyoshi Tani, Ryotaro Nakamura, Shunsuke Fujimoto, Tomotaka Takamatsu, Kazuaki Yashige, Masaki Kadoya, Yoshito Yamano, Michiyo Yamano, Tetsuhiro Nakamura, Takeshi Yaku, Hitoshi Matoba, Satoaki |
author_sort | Ito, Nobuyasu |
collection | PubMed |
description | AIMS: This study aimed to clarify the relationship between cardiovascular prognosis and left ventricular hypertrophy (LVH) in patients with severe aortic stenosis who underwent transcatheter aortic valve replacement (TAVR) and to investigate the relationship between cardiac sympathetic nerve (CSN) function and these factors using (123)I‐metaiodobenzylguanidine scintigraphy. METHODS AND RESULTS: In this single‐centre, retrospective observational study, 349 patients who underwent TAVR at our institution between July 2017 and May 2020 were divided into two groups: those with severe LVH pre‐operatively [severe LVH (+) group] and those without LVH pre‐operatively [severe LVH (−) group]. The rates of freedom from cardiovascular events (cardiovascular death and heart failure hospitalization) were compared. The relationship between changes in left ventricular mass index (LVMi) and changes in delay heart–mediastinum ratio (H/M) from before TAVR to 6 months after TAVR was also investigated. The event‐free rate was significantly lower in the severe LVH (+) group (87.1% vs. 96.0%, log‐rank P = 0.021). The severe LVH (+) group exhibited a significantly lower delay H/M value, scored by (123)I‐metaiodobenzylguanidine scintigraphy, than the severe LVH (−) group (2.33 [1.92–2.67] vs. 2.67 [2.17–3.68], respectively, P < 0.001). Moreover, the event‐free rate of post‐operative cardiovascular events was lower among patients with a delay H/M value < 2.50 than that among other patients (87.7% vs. 97.2%, log‐rank P = 0.012). LVMi was significantly higher (115 [99–130] vs. 90 [78–111] g/m(2), P < 0.001) and delay H/M value was significantly lower (2.53 [1.98–2.83] vs. 2.71 [2.25–3.19], P = 0.025) in the severe LVH (+) group than in the severe LVH (−) group at 6 months after TAVR. Patients with improved LVH at 6 months after TAVR also had increased delay H/M (from 2.51 [2.01–2.81] to 2.67 [2.26–3.02], P < 0.001), whereas those without improved LVH had no significant change in delay H/M (from 2.64 [2.23–3.06] to 2.53 [1.97–3.00], P = 0.829). CONCLUSIONS: Severe LVH before TAVR is a prognostic factor for poor post‐operative cardiovascular outcomes. LVH associated with aortic stenosis and CSN function are correlated, suggesting their involvement in LVH prognosis. |
format | Online Article Text |
id | pubmed-10053161 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2023 |
publisher | John Wiley and Sons Inc. |
record_format | MEDLINE/PubMed |
spelling | pubmed-100531612023-03-30 Left ventricular hypertrophy as a predictor of cardiovascular outcomes after transcatheter aortic valve replacement Ito, Nobuyasu Zen, Kan Takahara, Motoyoshi Tani, Ryotaro Nakamura, Shunsuke Fujimoto, Tomotaka Takamatsu, Kazuaki Yashige, Masaki Kadoya, Yoshito Yamano, Michiyo Yamano, Tetsuhiro Nakamura, Takeshi Yaku, Hitoshi Matoba, Satoaki ESC Heart Fail Original Articles AIMS: This study aimed to clarify the relationship between cardiovascular prognosis and left ventricular hypertrophy (LVH) in patients with severe aortic stenosis who underwent transcatheter aortic valve replacement (TAVR) and to investigate the relationship between cardiac sympathetic nerve (CSN) function and these factors using (123)I‐metaiodobenzylguanidine scintigraphy. METHODS AND RESULTS: In this single‐centre, retrospective observational study, 349 patients who underwent TAVR at our institution between July 2017 and May 2020 were divided into two groups: those with severe LVH pre‐operatively [severe LVH (+) group] and those without LVH pre‐operatively [severe LVH (−) group]. The rates of freedom from cardiovascular events (cardiovascular death and heart failure hospitalization) were compared. The relationship between changes in left ventricular mass index (LVMi) and changes in delay heart–mediastinum ratio (H/M) from before TAVR to 6 months after TAVR was also investigated. The event‐free rate was significantly lower in the severe LVH (+) group (87.1% vs. 96.0%, log‐rank P = 0.021). The severe LVH (+) group exhibited a significantly lower delay H/M value, scored by (123)I‐metaiodobenzylguanidine scintigraphy, than the severe LVH (−) group (2.33 [1.92–2.67] vs. 2.67 [2.17–3.68], respectively, P < 0.001). Moreover, the event‐free rate of post‐operative cardiovascular events was lower among patients with a delay H/M value < 2.50 than that among other patients (87.7% vs. 97.2%, log‐rank P = 0.012). LVMi was significantly higher (115 [99–130] vs. 90 [78–111] g/m(2), P < 0.001) and delay H/M value was significantly lower (2.53 [1.98–2.83] vs. 2.71 [2.25–3.19], P = 0.025) in the severe LVH (+) group than in the severe LVH (−) group at 6 months after TAVR. Patients with improved LVH at 6 months after TAVR also had increased delay H/M (from 2.51 [2.01–2.81] to 2.67 [2.26–3.02], P < 0.001), whereas those without improved LVH had no significant change in delay H/M (from 2.64 [2.23–3.06] to 2.53 [1.97–3.00], P = 0.829). CONCLUSIONS: Severe LVH before TAVR is a prognostic factor for poor post‐operative cardiovascular outcomes. LVH associated with aortic stenosis and CSN function are correlated, suggesting their involvement in LVH prognosis. John Wiley and Sons Inc. 2023-02-01 /pmc/articles/PMC10053161/ /pubmed/36725669 http://dx.doi.org/10.1002/ehf2.14305 Text en © 2023 The Authors. ESC Heart Failure published by John Wiley & Sons Ltd on behalf of European Society of Cardiology. https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open access article under the terms of the http://creativecommons.org/licenses/by-nc-nd/4.0/ (https://creativecommons.org/licenses/by-nc-nd/4.0/) License, which permits use and distribution in any medium, provided the original work is properly cited, the use is non‐commercial and no modifications or adaptations are made. |
spellingShingle | Original Articles Ito, Nobuyasu Zen, Kan Takahara, Motoyoshi Tani, Ryotaro Nakamura, Shunsuke Fujimoto, Tomotaka Takamatsu, Kazuaki Yashige, Masaki Kadoya, Yoshito Yamano, Michiyo Yamano, Tetsuhiro Nakamura, Takeshi Yaku, Hitoshi Matoba, Satoaki Left ventricular hypertrophy as a predictor of cardiovascular outcomes after transcatheter aortic valve replacement |
title | Left ventricular hypertrophy as a predictor of cardiovascular outcomes after transcatheter aortic valve replacement |
title_full | Left ventricular hypertrophy as a predictor of cardiovascular outcomes after transcatheter aortic valve replacement |
title_fullStr | Left ventricular hypertrophy as a predictor of cardiovascular outcomes after transcatheter aortic valve replacement |
title_full_unstemmed | Left ventricular hypertrophy as a predictor of cardiovascular outcomes after transcatheter aortic valve replacement |
title_short | Left ventricular hypertrophy as a predictor of cardiovascular outcomes after transcatheter aortic valve replacement |
title_sort | left ventricular hypertrophy as a predictor of cardiovascular outcomes after transcatheter aortic valve replacement |
topic | Original Articles |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10053161/ https://www.ncbi.nlm.nih.gov/pubmed/36725669 http://dx.doi.org/10.1002/ehf2.14305 |
work_keys_str_mv | AT itonobuyasu leftventricularhypertrophyasapredictorofcardiovascularoutcomesaftertranscatheteraorticvalvereplacement AT zenkan leftventricularhypertrophyasapredictorofcardiovascularoutcomesaftertranscatheteraorticvalvereplacement AT takaharamotoyoshi leftventricularhypertrophyasapredictorofcardiovascularoutcomesaftertranscatheteraorticvalvereplacement AT taniryotaro leftventricularhypertrophyasapredictorofcardiovascularoutcomesaftertranscatheteraorticvalvereplacement AT nakamurashunsuke leftventricularhypertrophyasapredictorofcardiovascularoutcomesaftertranscatheteraorticvalvereplacement AT fujimototomotaka leftventricularhypertrophyasapredictorofcardiovascularoutcomesaftertranscatheteraorticvalvereplacement AT takamatsukazuaki leftventricularhypertrophyasapredictorofcardiovascularoutcomesaftertranscatheteraorticvalvereplacement AT yashigemasaki leftventricularhypertrophyasapredictorofcardiovascularoutcomesaftertranscatheteraorticvalvereplacement AT kadoyayoshito leftventricularhypertrophyasapredictorofcardiovascularoutcomesaftertranscatheteraorticvalvereplacement AT yamanomichiyo leftventricularhypertrophyasapredictorofcardiovascularoutcomesaftertranscatheteraorticvalvereplacement AT yamanotetsuhiro leftventricularhypertrophyasapredictorofcardiovascularoutcomesaftertranscatheteraorticvalvereplacement AT nakamuratakeshi leftventricularhypertrophyasapredictorofcardiovascularoutcomesaftertranscatheteraorticvalvereplacement AT yakuhitoshi leftventricularhypertrophyasapredictorofcardiovascularoutcomesaftertranscatheteraorticvalvereplacement AT matobasatoaki leftventricularhypertrophyasapredictorofcardiovascularoutcomesaftertranscatheteraorticvalvereplacement |